|
|
Matrixx Initiatives, A Power Energy Generation Systems and Medicines lead small-cap volume in pre-market
|
RothmanResearch.com Stock Review for SQNM, SPIL, QLGC and COST
|
Simcere Pharmaceutical Group Files Annual Report on Form 20-F
|
Congress approves $106 bln for wars, swine flu, IMF
|
Congress approves 106 bln dollars for wars, swine flu, IMF
|
Senate approves $106 bln for wars, swine flu, IMF
|
Hold SGP Until the Acquisition
|
Pfizer Registration Statement Relating To Pending Wyeth Acquisition Declared Effective By SEC
|
Shire, J&J win key drug data case at top EU court
|
Shire, J&J win data exclusivity case at EU court
|
Street Still Quiet On Health Care Reform
|
Johnson & Johnson Announces Regulatory Clearance for Its Planned Acquisition of Cougar Biotechnology
|
Osiris Therapeutics to Present at Piper Jaffray Conference
|
Hemispherx Biopharma Appoints Robert Dickey IV to the New Position of Senior Vice President
|
Wall Street climbs, led by tech and biotech
|
34 Outstanding Teachers and Schools Receive $10,000 Amgen Award for Science Teaching Excellence
|
Tech, pharma advance leads Wall St higher
|
Keryx Biopharmaceuticals Inc. Regains Compliance With NASDAQ Listing Requirements
|
Antigenics' QS-21 Adjuvant Enters Pivotal Phase 3 Clinical Trial of GlaxoSmithKline's Malaria Vaccine
|
Monsanto Asserts DuPont Is Using Smokescreen to Obscure Problems With Its Failed Optimum(R) GAT(R) Product
|
